Unlocking The Potential of KLK13: A Protein with Multiple Functions

Target Name: KLK13

NCBI ID: G26085

KLK13

Unlocking The Potential of KLK13: A Protein with Multiple Functions

KLK13, also known as KLK13_HUMAN, is a protein that is expressed in various tissues of the human body, including the brain, pancreas, and heart. It is a member of the Kallikrein-related peptidases (KAPs) family, which includes several structurally similar proteins that are involved in the regulation of proteostasis, inflammation, and signaling pathways.

KLK13 is characterized by its unique catalytic mechanism, which involves the formation of a covalent bond between the peptidyl portion of the protein and a specific amino acid residue on the target protein. This mechanism allows KLK13 to cleave a wide variety of proteins with different lengths and modifications, making it a versatile tool for research and clinical applications.

Due to its unique properties, KLK13 has been identified as a potential drug target and biomarker. Several studies have suggested that KLK13 may play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key advantages of KLK13 as a drug target is its ability to interact with a wide range of proteins, which makes it a promising candidate for the development of antibodies or other therapeutic agents that can target specific variations in the protein sequence. This is especially important given the recent progress in the development of targeted therapies, which have shown promise in treating a range of diseases.

Another promising aspect of KLK13 is its role in the regulation of cellular signaling pathways. KLK13 has been shown to play a role in several signaling pathways that are involved in cell growth, differentiation, and survival. For example, KLK13 has been shown to be involved in the regulation of theNotch signaling pathway, which is involved in the regulation of stem cell proliferation and self-renewal.

In addition to its potential role in drug targeting and cellular signaling pathways, KLK13 is also a potential biomarker for several diseases. Given its role in the regulation of cellular signaling pathways, KLK13 may be involved in the regulation of cellular processes that are affected by a wide range of diseases. For example, KLK13 has been shown to be involved in the regulation of inflammation, which is a key aspect of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Furthermore, KLK13 has also been shown to play a role in the regulation of tissue repair and regeneration. This is important given the recent progress in the development of tissue engineering and regenerative medicine, which are aimed at replacing or repairing damaged tissues and organs. KLK13 may be involved in the regulation of the cellular processes that are responsible for tissue repair and regeneration.

In conclusion, KLK13 is a protein that is expressed in various tissues of the human body and has been shown to play a role in several cellular signaling pathways and processes that are involved in the regulation of cell growth, differentiation, and survival. Its unique catalytic mechanism and ability to interact with a wide range of proteins make it a promising candidate for the development of antibodies or other therapeutic agents that can target specific variations in the protein sequence. Furthermore, KLK13 has also been shown to play a role in the regulation of cellular signaling pathways and may be involved in the regulation of inflammation and tissue repair and regeneration. Further research is needed to fully understand the role of KLK13 in these processes and to determine its potential as a drug target and biomarker.

Protein Name: Kallikrein Related Peptidase 13

The "KLK13 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLK13 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets